1. Home
  2. HCM vs FORM Comparison

HCM vs FORM Comparison

Compare HCM & FORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • FORM
  • Stock Information
  • Founded
  • HCM 2000
  • FORM 1993
  • Country
  • HCM Hong Kong
  • FORM United States
  • Employees
  • HCM N/A
  • FORM N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • FORM Semiconductors
  • Sector
  • HCM Health Care
  • FORM Technology
  • Exchange
  • HCM Nasdaq
  • FORM Nasdaq
  • Market Cap
  • HCM 2.5B
  • FORM 2.7B
  • IPO Year
  • HCM N/A
  • FORM N/A
  • Fundamental
  • Price
  • HCM $15.92
  • FORM $30.04
  • Analyst Decision
  • HCM Strong Buy
  • FORM Buy
  • Analyst Count
  • HCM 1
  • FORM 7
  • Target Price
  • HCM $28.00
  • FORM $39.33
  • AVG Volume (30 Days)
  • HCM 44.4K
  • FORM 922.4K
  • Earning Date
  • HCM 08-07-2025
  • FORM 07-30-2025
  • Dividend Yield
  • HCM N/A
  • FORM N/A
  • EPS Growth
  • HCM N/A
  • FORM N/A
  • EPS
  • HCM 0.53
  • FORM 0.57
  • Revenue
  • HCM $602,197,000.00
  • FORM $764,554,000.00
  • Revenue This Year
  • HCM $15.00
  • FORM $2.18
  • Revenue Next Year
  • HCM $19.91
  • FORM $7.14
  • P/E Ratio
  • HCM $5.55
  • FORM $53.69
  • Revenue Growth
  • HCM N/A
  • FORM 8.30
  • 52 Week Low
  • HCM $11.51
  • FORM $22.58
  • 52 Week High
  • HCM $21.50
  • FORM $51.68
  • Technical
  • Relative Strength Index (RSI)
  • HCM 43.91
  • FORM 42.52
  • Support Level
  • HCM $14.64
  • FORM $27.54
  • Resistance Level
  • HCM $16.17
  • FORM $30.62
  • Average True Range (ATR)
  • HCM 0.50
  • FORM 1.56
  • MACD
  • HCM -0.31
  • FORM -0.08
  • Stochastic Oscillator
  • HCM 24.90
  • FORM 39.61

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

Share on Social Networks: